Lucia Rinaldi
Bari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Sacituzumab govitecan vs. chemotherapy for metastatic breast cancer: a meta-analysis on safety outcomes.
Journal: Future oncology (London, England)
Published: June 12, 2024
Explainable 3D CNN based on baseline breast DCE-MRI to give an early prediction of pathological complete response to neoadjuvant chemotherapy.
Journal: Computers in biology and medicine
Published: June 28, 2023
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Journal: Frontiers in oncology
Published: January 27, 2023
Analyzing breast cancer invasive disease event classification through explainable artificial intelligence.
Journal: Frontiers in medicine
Published: December 05, 2022
Machine learning survival models trained on clinical data to identify high risk patients with hormone responsive HER2 negative breast cancer.
Journal: Scientific reports
Published: November 04, 2022
Prognostic power assessment of clinical parameters to predict neoadjuvant response therapy in HER2-positive breast cancer patients: A machine learning approach.
Journal: Cancer medicine
Published: October 17, 2022
Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer.
Journal: Expert opinion on investigational drugs
Published: May 16, 2022
Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis.
Journal: Cells
Published: April 19, 2022
KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancer.
Journal: Future oncology (London, England)
Published: April 05, 2022
Robustness Evaluation of a Deep Learning Model on Sagittal and Axial Breast DCE-MRIs to Predict Pathological Complete Response to Neoadjuvant Chemotherapy.
Journal: Journal of personalized medicine
Published: March 25, 2022
An Invasive Disease Event-Free Survival Analysis to Investigate Ki67 Role with Respect to Breast Cancer Patients' Age: A Retrospective Cohort Study.
Journal: Cancers
Published: March 24, 2022
Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY.
Journal: Expert review of gastroenterology & hepatology
Published: February 28, 2022
Last Updated: 09/26/2026